Editorial: Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients With Metabolic Dysfunction-Do Existing Scores Clear the Bar? Authors' Reply.
사설/논평
0/5 보강
APA
Patmore LA, Sonneveld MJ (2026). Editorial: Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients With Metabolic Dysfunction-Do Existing Scores Clear the Bar? Authors' Reply.. Alimentary pharmacology & therapeutics, 63(3), 431-432. https://doi.org/10.1111/apt.70410
MLA
Patmore LA, et al.. "Editorial: Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients With Metabolic Dysfunction-Do Existing Scores Clear the Bar? Authors' Reply.." Alimentary pharmacology & therapeutics, vol. 63, no. 3, 2026, pp. 431-432.
PMID
41074799
같은 제1저자의 인용 많은 논문 (3)
- Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease.
- Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosis.
- Prediction of Hepatocellular Carcinoma and Liver-related Events in Anti-hepatitis D Virus-positive Individuals.